查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198491

无菌过滤市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Sterile Filtration Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

无菌过滤市场预计在预测期内的复合年增长率为 8%。

灭菌或过滤可去除细菌、真菌、病毒和原生动物等微生物，这些微生物会污染药物、疫苗或替代品、化学品、食品或其他产品并构成健康风险。至关重要的是，COVID-19 大流行已经对市场产生重大影响。 在大流行期间，对 COVID-19 疫苗和疗法的需求不断增长推动了无菌过滤市场。 根据 2021 年 5 月发表在 Computational and Structural Biotechnology Journal 上的一篇论文，有 184 种候选疫苗处于临床前研究阶段，88 种处于临床试验阶段。 无菌过滤是回收 COVID-19 候选疫苗的无菌过程中的关键步骤，因为它支持高选择性和有效的候选疫苗。 因此，COVID-19 增加了对无菌过滤技术的需求，并且由于无菌过滤是药物製剂开发的关键步骤之一，预计在预测期内将继续保持同样的趋势。

慢性病的增加以及製药和生物製药行业的增长推动了市场的发展。 慢性病包括癌症、心血管疾病、神经系统疾病等，有望推动市场增长。 根据美国癌症协会 2021 年的报告，2021 年美国将有约 190 万癌症患者（970,250 名男性和 927,910 名女性）被诊断出患有癌症，并有 608,570 名美国人死于 因此，慢性病的高负担和生命科学研究与开发的高投资有望推动市场增长。

生物技术和製药公司为扩大产品线和一次性技术的地理覆盖范围而增加的支出预计将增加对无菌过滤的需求，从而促进分析市场的增长。 例如，2021 年 7 月，Cytiva 和 Pall 公司宣布，他们将在未来两年内投资 15 亿美元，以满足对生物技术解决方案日益增长的需求，包括生物反应器和一次性过滤器等一次性技术。将分配超过3 亿美元用于扩大其在美国和英国的业务。

因此，预计上述因素等因素将在预测期内提振市场。 然而，无菌过滤的高成本可能会抑制市场增长。

除菌过滤的市场趋势

预计滤芯过滤器市场将出现显着增长

滤筒式过滤器因其高纳污能力、长寿命、成本效益、可靠性和卓越性能而有望增长。 筒式过滤器是管式过滤装置，用于各种行业的过滤，从高纯水的预过滤到最终产品加工再到化学过滤。 它也广泛用于废水处理，因为它甚至对微量污染物也有效。

生物製药和製药公司大幅推高了研发成本。 根据美国国会预算办公室2021年公布的数据，医药领域的研发支出预计将从2019年的8300万美元增长到2020年的2000多亿美元。 因此，公司增加研发投资将增强公司采用创新技术和过滤系统的能力，从而促进市场增长。

此外，主要参与者不断增加的技术开发、产品批准和合作伙伴关係将有助于扩大市场。 例如，2021 年 10 月，派克汉尼汾公司的工业气体过滤和发电部门推出了两款新的售后滤筒。 这些过滤器专为专业应用而设计，可帮助客户提高利润。 这些产品的推出预计将增加对筒式过滤器的需求，从而推动该领域的增长。

因此，上述因素有望在预测期内推动该行业的增长。

北美将在市场中占有重要地位，预计在预测期内也会如此

由于研发支出增加和无菌过滤器技术不断进步等因素，预计北美将在膜过滤器领域占据很大份额。 多家製药公司和政府机构最近增加了研发支出，预计这将在预测期内推动市场增长。 例如，根据3M Company Annual Report-2021，2021年将投入19.94亿美元用于研发，而2020年为18.78亿美元。 丹纳赫公司在 2021 年的研发投资为 17.42 亿美元，而 2020 年为 13.48 亿美元。 预计这将增加过滤系统中新技术的采用，从而提供更高的准确性并减少污染参数，从而刺激市场的增长。

主要市场进入者的出现和产品开发的先进技术有望在该领域确立主导地位。 例如，2021 年 10 月，美国国家生物製药製造创新研究所 (NIIMBL) 批准了 300 万美元的拨款，用于六台新的生物製药製造设备。 北卡罗来纳州立大学、马萨诸塞大学、佐治亚大学、密歇根大学、特拉华大学、卡内基梅隆大学和其他大学将获得资助。 预计按地区增加研发投资将推动市场增长。

薄膜过滤器和相关过滤系统的新产品发布预计将在预测期内推动该地区的市场增长。 例如，2021 年 11 月，杜邦水务解决方案 (DWS) 宣布推出 TapTec LC HF-4040，这是一种结合了高流量和可靠性的反渗透膜过滤器，适用于商业建筑。

无菌过滤市场竞争对手分析

由于全球和本地参与者的存在，无菌过滤器市场竞争适中。 随着无菌过滤器的使用越来越多，少数中小型公司有望进入市场，并有望在未来占据相当大的份额。 无菌过滤器市场上的知名公司有 Danaher Corporation、Merck KGaA、ThermoFisher Scientific Inc.、Sartorius AG、GE Healthcare、3M、Cole-Parmer Instrument Company, LLC、Sterlitech Corporation、Eaton Corporation、Porvair Filtration Group 等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 增加慢性病负担
    • 製药和生物製药行业的发展
  • 市场製约因素
    • 无菌过滤成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 筒式过滤器
    • 胶囊过滤器
    • 注射器过滤器
    • 其他膜过滤器
    • 配饰
  • 最终用户
    • 製药和生物技术公司
    • 委託研究机构
    • 研究所
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • 3M
    • Cole-Parmer Instrument Company, LLC
    • Danaher Corporation
    • Eaton Corporation
    • GE Healthcare
    • Merck KGaA
    • Sartorius AG
    • Porvair Filtration Group
    • Sterlitech Corporation
    • ThermoFisher Scientific Inc.
    • Prominent GmbH
    • Koch Membrane Systems Inc.

第7章 市场机会今后动向

简介目录
Product Code: 70529

The sterile filtration market is expected to register a CAGR of 8% over the forecast period.

The global spread of COVID-19 had a significant impact on the market because sterilization or filtration is critical for the removal of microbes, such as bacteria, fungi, viruses, and protozoa, that may contaminate medicinal drugs, vaccines, or alternative substances, chemicals, food, and other products, posing health risks. The growing demand for COVID-19 vaccines and treatment medications propelled the sterile filtration market during the pandemic. According to an article published in the Computational and Structural Biotechnology Journal in May 2021, there were 184 vaccine candidates in preclinical research and 88 under clinical trials. The sterile filtering method is an important step in the aseptic process for recovering COVID-19 vaccine candidates since it supports high selectivity and effective vaccine candidates. Thus, COVID-19 enhanced the demand for sterile filtration techniques and is expected to follow the same trend over the forecast period, as sterile filtration is one of the important procedures in drug formulation development.

The market is driven by the rising prevalence of chronic diseases and the the growing pharmaceutical and biopharmaceutical industries. Chronic diseases include cancer, cardiovascular, neurological and others diseases, and are expected to propel the growth of the market. According to the American Cancer Society's 2021 report, about 1.9 million cancer cases (970,250 in males and 927,910 in females) were diagnosed in 2021 in the United States, and 608,570 Americans died from it. Thus, the high burden of chronic diseases and high investments in life science research and development are expected to drive market growth.

With increasing expenditures by biotechnology and pharmaceutical businesses in expanding their product lines and geographical reach in single-use technologies, the need for sterile filtration is predicted to increase, bolstering the growth of the analyzed market. For instance, in July 2021, Cytiva and Pall Corporation revealed a USD 1.5 billion investment over the next two years to meet the rising demand for biotechnology solutions, with over USD 300 millionallocated for single-use technologies, such as bioreactor and single-use filters, to expand operations in the United States and the United Kingdom.

Thus, all the above-mentioned factors are expected to boost the market over the forecast period. However, the high cost of sterile filtration may restrain market growth.

Sterile Filtration Market Trends

Cartridge Filter Segment Expected to Exhibit Significant Market Growth

Cartridge filters are expected to grow because of their high dirt-holding capacity, extended service life, cost-effectiveness, reliability, and good performance. Cartridge filters are tubular filtration equipment used in various industries for filtration, ranging from pre-filtering high-purity water to final product processing and chemical filtration. They are widely used in wastewater treatment as they are effective against small contaminants.

Biopharmaceutical and pharmaceutical companies boost their research and development spending significantly. According to the data published by the Congressional Budget Office in 2021, pharmaceutical sectors were expected to spend over USD 200 billion on research and development in 2020, up from USD 83 million in 2019. Thus, increased investments in research and development by corporations boost the company's ability to adopt innovative technologies and filtration systems, hence improving market growth.

Furthermore, technological developments and increased product approvals, as well as partnerships by key players, assist market expansion. For instance, in October 2021, the Industrial Gas Filtration and Generation Division of Parker Hannifin Corporation launched two new aftermarket cartridge filters. These filters are designed to meet special applications to help customers improve their bottom line. These launches are expected to increase the demand for cartridge filters, hence boosting the growth of the segment.

Thus, the aforementioned factors are expected to boost the growth of segment over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant share of the market in the membrane filters segment due to factors such as rising research and development expenditure and increasing technological advancements in sterile filters. Various pharmaceutical businesses and government organizations recently increased their R&D spending, which is expected to boost market growth throughout the forecast period. For instance, as per the annual reports-2021 of 3M Company, in 2021, it invested USD 1.994 billion in research and development, compared to USD 1.878 billion in 2020. Danaher Corporation invested USD 1,742 million in its research and development in 2021, compared to USD 1,348 million in 2020. This is expected to increase the adoption of new technologies in filtration systems, which provide better accuracy and reduce fouling parameters, thereby fueling the market growth.

The presence of key market participants and advanced technology for product development are expected to establish the dominance of this area. For instance, in October 2021, the United States National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) approved a USD 3 million grant for six new biopharmaceutical manufacturing devices. North Carolina State University, the University of Massachusetts, the University of Georgia, the University of Michigan, the University of Delaware, and Carnegie Mellon University are among the institutions that will receive funding. The increase in regional R&D investments is expected to boost market growth.

New product launches of membrane filters and related filtering systems are likely to fuel market growth over the forecast period in the region. For instance, in November 2021, DuPont Water Solutions (DWS) introduced the TapTec LC HF-4040 reverse osmosis membrane filter, which is meant to combine high flow rates with reliability to be used in commercial buildings.

Sterile Filtration Market Competitor Analysis

The market for sterile filters is moderately competitive with the presence of global and local companies. With the rising use of sterile filters, few small to mid-sized companies are expected to enter the market and are believed to gain substantial shares in the future. The well-known companies in the sterile filtration market are Danaher Corporation, Merck KGaA, ThermoFisher Scientific Inc., Sartorius AG, GE Healthcare, 3M, Cole-Parmer Instrument Company, LLC, Sterlitech Corporation, Eaton Corporation, and Porvair Filtration Group.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Growing Pharmaceutical and Biopharmaceutical Industries
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Sterile Filtration
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Cartridge Filter
    • 5.1.2 Capsule Filter
    • 5.1.3 Syringe Filter
    • 5.1.4 Other Membrane Filters
    • 5.1.5 Accessories
  • 5.2 By End User
    • 5.2.1 Pharmaceutical and Biopharmaceutical Companies
    • 5.2.2 Contract Research Organization
    • 5.2.3 Research Laboratories
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cole-Parmer Instrument Company, LLC
    • 6.1.3 Danaher Corporation
    • 6.1.4 Eaton Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Merck KGaA
    • 6.1.7 Sartorius AG
    • 6.1.8 Porvair Filtration Group
    • 6.1.9 Sterlitech Corporation
    • 6.1.10 ThermoFisher Scientific Inc.
    • 6.1.11 Prominent GmbH
    • 6.1.12 Koch Membrane Systems Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS